作者
Philip A Cole, Cecil H Robinson
发表日期
1990/11
来源
Journal of medicinal chemistry
卷号
33
期号
11
页码范围
2933-2942
出版商
American Chemical Society
简介
The role of estrogen blockadein the treatment of certain neoplastic disorders has been of wide interest for a number of years. It has long been known that specific tumors, particularly breast cancer in women, can grow more rapidly in proportion to the surrounding levels of estrogen. 1 Recent advances in the areas of molecular and cellular biology have led to a more detailed understanding of es-trogen action. The estrogen receptor gene has been cloned, sequenced, and expressed. 2 The estrogen receptor protein seems to be composed of two nonoverlappingfunctional domains: the first domain has a high affinity for estrogen and the second has a high affinity for DNA. Upon binding of estrogen to the first domain, a conformational change is apparently triggered in the second domain, allowing it to productively interact with a specific sequence of DNA nucleotides known as a transcriptional enhancer region. The result …
引用总数
19911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320247714101317181211131191211614107814201611712888797881
学术搜索中的文章